Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
Not Applicable
Completed
- Conditions
- Deep Vein Thrombosis
- Interventions
- Other: Doppler Echo
- Registration Number
- NCT04363528
- Lead Sponsor
- Versailles Hospital
- Brief Summary
The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU.
This is a monocentric interventional study (RIPH 2).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Patient > or =18 years
- Hospitalization in intensive care
- PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of taste, anosmia) associated with compatible radiological signs
Exclusion Criteria
- Pregnancy in progress
- Patient <18 years
- Patients deprived of freedoms or under guardianship
- Patient or family opponent of protocol participation
- patient on curative anticoagulant for more than 48H00
- impossible Venous Doppler Echo
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Doppler Echo Doppler Echo patients will have a Doppler Echo when they enter ICU (within 48 hours) and a second Doppler Echo 7 days later
- Primary Outcome Measures
Name Time Method Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU Day 7 Deep vein thrombosis at Doppler echo
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre Hospitalier de Versailles
🇫🇷Le Chesnay, France